Find your next paid study

Vividion Therapeutics, Inc.NCT05954312

~$150 – $4,200

Actual pay is set by the research site.

Phase 1

A Multi-Center, Open-label, Phase 1/2 Trial of the Safety and Efficacy of MVX-220 Gene Therapy Administered by Intra-Cisterna Magna Injection to Participants With Angelman Syndrome

The purpose of this study is to evaluate the safety and efficacy of MVX-220 gene therapy in children and adults with Angelman syndrome with UBE3A gene deletion…

Angelman Syndrome

MavriX Bio, LLCNCT07181837

~$150 – $4,200

Actual pay is set by the research site.

A Prospective, Longitudinal, Observational Cohort Study of Older Adults From Under-resourced/Underrepresented Communities Diagnosed With Subjective Cognitive Decline (SCD) or Mild Cognitive Disorder (MCI) Through Standard of Care Tele-Cog Visits (Tele-Cog)

The purpose of this study is to establish a longitudinal cohort of older adults with Subjective Cognitive Decline (SCD) or Mild Cognitive Impairment (MCI): 1) …

Mild Cognitive ImpairmentSubjective Cognitive Decline

Ohio State UniversityNCT06542458

Actual pay is set by the research site.

Phase 1

An Open-Label, Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of the CTPS1 Inhibitor STP938 in Adult Subjects With Advanced Solid Tumors, With a Safety Expansion in Advanced CTPS2 Null Ovarian Cancer

The Phase 1a part of the study is a dose escalation of STP938 as a monotherapy. The Phase 1b part of the study is a safety expansion cohort of STP938 as a mon…

Solid Tumor

Step Pharma, SASNCT06297525

~$150 – $4,200

Actual pay is set by the research site.

Phase 1

A Phase I/IB Study of Ropeginterferon in Patients With Cutaneous T-Cell Lymphoma (CTCL)

This is a single-center, phase I/IB study to identify the recommended phase II dose of Ropeginterferon-alfa 2b (P1101) in patients with CTCL who have failed at…

Cutaneous T Cell Lymphoma

H. Lee Moffitt Cancer Center and Research InstituteNCT07047885

~$150 – $3,000

Actual pay is set by the research site.

Maternal MorbidityAntenatal HealthNeonatal Morbidity+2 more

Partnering With Antenatal Navigators to Transform Health in Pregnancy

The Partnering with Antenatal Navigators to Transform Health in Pregnancy (PATH) study aims to evaluate whether an antenatal patient navigation program improve…

Northwestern UniversityNCT06941974

Actual pay is set by the research site.

Minimal Sedation During Total Knee Arthroplasty: A Prospective Randomized Control Trial

This study will test the use of active noise cancelling headphones with music or a movie during knee replacement surgery. Feedback from the surgical team and f…

Total Knee Arthroplasty

Actual pay is set by the research site.

Mayo ClinicNCT07371390

Brighter Bites & Legacy Community Health Produce Rx: Evaluating the Feasibility and Effectiveness of a School-based Clinical Nutrition Program With Produce Prescription

The purpose of this study is to assess the effectiveness of the produce prescription program at improving weight status and obesity-related health outcomes of …

Child Obesity

The University of Texas Health Science Center, HoustonNCT06407284

Actual pay is set by the research site.

Phase 2

A Phase II Parallel Arm Study of SACITUZUMAB GOVITECAN-HZIY in Patients With Advanced Thymoma and Thymic Carcinoma

The goal of this clinical trial is to study the effect of sacituzumab govitecan-hziy in adult patients with advanced thymoma and thymic carcinoma after progres…

ThymomaThymic Carcinoma

Georgetown UniversityNCT06248515

~$75 – $2,000

Actual pay is set by the research site.

Cystic FibrosisCystic Fibrosis-related DiabetesCystic Fibrosis With Intestinal Manifestations

The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes

This study will evalute the effect of a low glycemic load (LGL diet on dysglycemia, insulin requirements, DXA-derived body composition, gastrointestinal sympto…

Rhode Island HospitalNCT05723445

Actual pay is set by the research site.

Enhancing Heart Allograft Function With the OCS Heart System (ENHANCE) Trial

This trial is designed to evaluate the safety and effectiveness of the novel OCS Solution and OCS Functional Enhancer (OFE) to support FDA approval in both DBD…

Heart Transplant

~$10 – $1,125

Actual pay is set by the research site.

TransMedicsNCT07145515

Chronic PainMental Health DisordersBehavioral Health Challenges+1 more

Evaluating the Acceptability, Feasibility and Usability of Various Digital Biopsychosocial Conversational Data Collection Software in a Patient Population With Chronic Pain

This research study is being conducted to evaluate digital software tools that collect health information through conversations. The study will test how accept…